Stay updated on REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 removed, a minor update to the page's revision information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:45:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A footer revision tag was updated from v3.4.0 to v3.4.1; no changes to the main study details or user-facing features were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:58:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    These changes are minor UI and metadata updates: the glossary toggle label, capitalization tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new 'Revision: v3.4.0' tag with corresponding deletions of the old wording. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T22:15:47.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page. No other study content or functionality changes are evident.
    Difference
    0.1%
    Check dated 2026-01-14T07:25:18.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Florida listed as a location, and removed the Florida Locations reference. The revision note was updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.2%
    Check dated 2025-12-23T22:31:41.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:37:23.000Z thumbnail image

Stay in the know with updates to REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.